HOME >> MEDICINE >> NEWS
Medication shows modest benefit in reducing weight, improving HDL, triglyceride levels

Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels, according to a study in the February 15 issue of JAMA.

Approximately two-thirds of U.S. adults are overweight or obese, which greatly increases the risk of developing diabetes mellitus and cardiovascular disease and death from related causes. Researchers believe that besides weight loss, obesity management should target improvement in certain cardiometabolic risk factors, which include abnormal cholesterol and glucose (blood sugar) levels and excess weight around the waist, according to background information in the article. Long-term weight management remains a challenge for patients and clinicians.

F. Xavier Pi-Sunyer, M.D., of St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, and colleagues evaluated the efficacy and safety of the weight-loss medication rimonabant in conjunction with diet and exercise in promoting reductions in body weight and waist circumference, long-term weight maintenance, and reduction of cardiometabolic risk factors in obese and higher risk overweight patients. The randomized, double-blind, placebo-controlled study, conducted from August 2001 to April 2004, included 3,045 adults who were obese (body mass index 30 or greater) or overweight (body mass index greater than 27 and treated or untreated hypertension [high blood pressure] or dyslipidemia [abnormal levels of certain lipids and lipoproteins in the blood]). Patients were randomized to receive placebo, 5 mg/d of rimonabant, or 20 mg/d of rimonabant for 1 year. Rimonabant-treated patients were re-randomized to receive placebo or continued to receive the same rimonabant dose while the placebo group continued to receive placebo during year 2.

Year 1 of the study was completed by 51 percent of patients in the placebo group, 51 percent in the 5 mg of rimonabant
'"/>

Contact: Elizabeth Streich
212-305-6535
JAMA and Archives Journals
14-Feb-2006


Page: 1 2

Related medicine news :

1. Medication does not appear to offer benefit for certain heart attack patients undergoing PCI
2. Medication errors affect childrens leukemia treatment
3. Medication may promote opening of arteries following stroke
4. IOM Advisory: Preventing Medication Errors News Conference on July 20
5. Medication use linked to farmers injuries
6. Medication plus oral contraceptive may improve female pattern hair loss
7. Medication reduces risk of adverse events for patients with acute coronary syndromes undergoing PCI
8. Medications that lower blood pressure linked to reduced risk of Alzheimers disease
9. Medication plus beta-blocker helps prevent shocks from implantable cardioverter defibrillator
10. Medications and cough syrups may cause cavities
11. Medication reduces risk of heart irregularities after cardiac surgery

Post Your Comments:
(Date:5/27/2015)... CA (PRWEB) May 27, 2015 Khanna Vision ... the art web portal focussed on keratoconus eye disease ... relentless progressive disease has its onset in the teenage years. ... The cornea or the front clear part of the eye ... pressure in the eye. It results in poor vision which ...
(Date:5/27/2015)... Wis. (PRWEB) May 27, 2015 “We ... Julie Schuller, MD, executive vice president and vice president ... this grant makes possible allows us to provide comprehensive ... of our community.” , SSCHC provides clinical care and ... over 35,000 people in 2014, many of whom took ...
(Date:5/27/2015)... May 27, 2015 Hundreds of ... behalf of individuals who allegedly suffered gynecomastia (male ... use of the antipsychotic drug continue to move ... in Pennsylvania’s Philadelphia Court of Common Pleas. According ... its bellwether trial program, as the third trial ...
(Date:5/27/2015)... 27, 2015 With the launch of ... robust Network Management Module (NMM) tool, monitoring provider-network adequacy ... issue of Atlantic Information Services, Inc.’s (AIS) Medicare Advantage ... tool, as well as analysis from industry experts on ... changes coming to the NMM were announced at CMS’s ...
(Date:5/27/2015)... 27, 2015 In today's healthcare landscape, ... it can be challenging for doctors and hospitals to ... treatments. , Austin-based HealthTronics, Inc. is ... mobile medical therapies for clinically sophisticated applications. The company ... acquisition of Laser Ventures, Inc ., a mobile ...
Breaking Medicine News(10 mins):Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3
(Date:5/27/2015)... 27, 2015 Research and ... the  "North America Portable X Ray Devices Market ...  report to their offering.       (Logo: ... market for Portable X-Ray Devices is ... 2014 to 2020 X-Ray is a ...
(Date:5/27/2015)... 27, 2015 The global vitreoretinal ... market with analysis and forecast of revenue. This market ... is estimated to grow at a CAGR of 8.9 ... the TOC of the global vitreoretinal surgery devices market ... provided. This report also provides a glimpse of the ...
(Date:5/27/2015)... 2015  Marcio Donatelli, a senior marketing associate with the animal health ... volunteer work in a healthcare setting in Bangkok, Thailand ... for people in need with respect and dignity is the guiding star ... -based Elanco employee in a LillyPad blog . Donatelli ... , Colombia , France , ...
Breaking Medicine Technology:North America Portable X Ray Devices Market Report 2015 - Growth, Trends And Forecasts 2014-2019 2Vitreoretinal Surgery Devices Market is Expected to Reach $1,017.8 Million by 2019, at a CAGR of 8.9 % From 2014 to 2019 2Vitreoretinal Surgery Devices Market is Expected to Reach $1,017.8 Million by 2019, at a CAGR of 8.9 % From 2014 to 2019 3Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3
Cached News: